Keyword search
Filter results by
Search HelpKeyword(s)
Survey or statistical program
Results
All (10)
All (10) ((10 results))
- Articles and reports: 88-003-X20010035970Geography: CanadaDescription:
This article looks at the use of biotechnology, obstacles to commercialization and information sources on biotechnology.
Release date: 2001-10-31 - Articles and reports: 88-003-X20010035971Geography: CanadaDescription:
Biotechnology firms are generally flexible and innovative in their approaches to survival and growth in Canada and also on the world stage. Read an overview of some of the business strategies and practices used by biotechnology firms to conduct research and development and for some, commercialization of their products.
Release date: 2001-10-31 - Articles and reports: 88-003-X20010035972Geography: CanadaDescription:
Based on information from the 1997 Biotechnology Firm Survey, we know biotechnology firms generated $813 million in biotech revenues; employed 9,000 people in biotech-related activities and had almost 9,000 products across all stages of development. Explore issues such as - What are the main features of this sector? What is the extent of networking activities by the firms? And what kinds of problems are they facing when selling their products?
Release date: 2001-10-31 - 4. Canadian Biotechnology Industrial Activities: Features from the 1997 Biotechnology Survey ArchivedArticles and reports: 88F0006X2001012Description:
As of 1997, Canadian biotech industry was made of 282 core firms. Of these, 214 were small firms with less than 50 employees, 37 were medium firms with 51 to 150 employees, and 31 were large firms with over 150 employees. They earned $813 million from biotech products sales, $311 million of which were from exports. They employed 9,000 people in biotech related activities and had 8,924 products at all stages of development. Private placements, venture capital and labour sponsored funds were these firms main sources of financing capital. Access to capital was the most serious obstacle faced by the biotech firms in 1997. Marketing and distribution were their major reasons for entertaining strategic alliances, while universities were their most preferred R&D partners.
Release date: 2001-09-25 - Articles and reports: 88F0006X2001011Description:
This paper provides a summary of the strategies and business practices of biotechnology firms, and information on the business environment faced by these firms. These issues, considered in conjunction with information on revenue, research and development, import and export, product pipeline and human resources characteristics of biotechnology firms, contribute to a more comprehensive portrait of the biotechnology sector in Canada.
Release date: 2001-08-28 - 6. Biotechnology scientific activities in selected federal government departments and agencies, 1999-2000 ArchivedArticles and reports: 88-001-X20010037919Description:
Data on science and technology (S&T) expenditures and person-years allocated to biotechnology for the year 1999-2000 were collected from selected federal departments and agencies. The criterion for selection was significant activity in this field. Survey results contribute to the work of the Canadian Biotechnology Strategy.
Release date: 2001-05-18 - Articles and reports: 88-001-X20010047917Description:
Biotechnology is an enabling technology - one that has been compared to electricity or microelectronics - because it has the potential to transform production processes, products and services in a wide range of sectors of the economy. At present, major applications of biotechnology are taking place in health, agriculture and agrifood, and natural resources (e.g. forestry and mining). This survey is intended to quantify the level of industrial activity in biotechnology research and development by sector of application and to reveal trends in spending.
Release date: 2001-05-18 - Articles and reports: 88-003-X20010025752Geography: CanadaDescription:
With revenues of almost $2 billion, what are the characteristics and activities of firms that use or develop biotechnology as an important part of their firm's activities? Human Health biotechnology dominates both the revenue and spending in the biotechnology sector. Read this enlightening article for further details including dicussion on the geographic location and size of Canadian biotechnology firms.
Release date: 2001-05-02 - 9. Biotechnology Use and Development - 1999 ArchivedArticles and reports: 88F0006X2001007Description:
This paper provides estimates for firms actively involved in the development of new products and processes using biotechnologies. The survey examines the use of biotechnology and the development of biotechnologies in Canada's industrial sector for the 1999 fiscal year. The Biotechnology Use and Development Survey - 1999 was conducted as part of a project to develop biotechnology statistics and was funded under the Canadian Biotechnology Strategy. Several departments and agencies provided important inputs at various stages of the survey. They are Industry Canada, the Canadian Biotechnology Secretariat, Agriculture Canada, the National Research Council, the Canadian Institutes for Health Research, Natural Resources Canada, Department of Foreign Affairs and International Trade, Health Canada, and Environment Canada.
Release date: 2001-03-30 - 10. Internationally Comparable Indicators on Biotechnology: A Stocktaking, a Proposal for Work and Supporting Material ArchivedArticles and reports: 88F0017M2001009Geography: CanadaDescription:
This paper examines the call for an international effort to co-ordinate the measuring of biotechnology so that the ensuing statistics and indicators maintain some level of international comparability.
Release date: 2001-02-15
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (10)
Analysis (10) ((10 results))
- Articles and reports: 88-003-X20010035970Geography: CanadaDescription:
This article looks at the use of biotechnology, obstacles to commercialization and information sources on biotechnology.
Release date: 2001-10-31 - Articles and reports: 88-003-X20010035971Geography: CanadaDescription:
Biotechnology firms are generally flexible and innovative in their approaches to survival and growth in Canada and also on the world stage. Read an overview of some of the business strategies and practices used by biotechnology firms to conduct research and development and for some, commercialization of their products.
Release date: 2001-10-31 - Articles and reports: 88-003-X20010035972Geography: CanadaDescription:
Based on information from the 1997 Biotechnology Firm Survey, we know biotechnology firms generated $813 million in biotech revenues; employed 9,000 people in biotech-related activities and had almost 9,000 products across all stages of development. Explore issues such as - What are the main features of this sector? What is the extent of networking activities by the firms? And what kinds of problems are they facing when selling their products?
Release date: 2001-10-31 - 4. Canadian Biotechnology Industrial Activities: Features from the 1997 Biotechnology Survey ArchivedArticles and reports: 88F0006X2001012Description:
As of 1997, Canadian biotech industry was made of 282 core firms. Of these, 214 were small firms with less than 50 employees, 37 were medium firms with 51 to 150 employees, and 31 were large firms with over 150 employees. They earned $813 million from biotech products sales, $311 million of which were from exports. They employed 9,000 people in biotech related activities and had 8,924 products at all stages of development. Private placements, venture capital and labour sponsored funds were these firms main sources of financing capital. Access to capital was the most serious obstacle faced by the biotech firms in 1997. Marketing and distribution were their major reasons for entertaining strategic alliances, while universities were their most preferred R&D partners.
Release date: 2001-09-25 - Articles and reports: 88F0006X2001011Description:
This paper provides a summary of the strategies and business practices of biotechnology firms, and information on the business environment faced by these firms. These issues, considered in conjunction with information on revenue, research and development, import and export, product pipeline and human resources characteristics of biotechnology firms, contribute to a more comprehensive portrait of the biotechnology sector in Canada.
Release date: 2001-08-28 - 6. Biotechnology scientific activities in selected federal government departments and agencies, 1999-2000 ArchivedArticles and reports: 88-001-X20010037919Description:
Data on science and technology (S&T) expenditures and person-years allocated to biotechnology for the year 1999-2000 were collected from selected federal departments and agencies. The criterion for selection was significant activity in this field. Survey results contribute to the work of the Canadian Biotechnology Strategy.
Release date: 2001-05-18 - Articles and reports: 88-001-X20010047917Description:
Biotechnology is an enabling technology - one that has been compared to electricity or microelectronics - because it has the potential to transform production processes, products and services in a wide range of sectors of the economy. At present, major applications of biotechnology are taking place in health, agriculture and agrifood, and natural resources (e.g. forestry and mining). This survey is intended to quantify the level of industrial activity in biotechnology research and development by sector of application and to reveal trends in spending.
Release date: 2001-05-18 - Articles and reports: 88-003-X20010025752Geography: CanadaDescription:
With revenues of almost $2 billion, what are the characteristics and activities of firms that use or develop biotechnology as an important part of their firm's activities? Human Health biotechnology dominates both the revenue and spending in the biotechnology sector. Read this enlightening article for further details including dicussion on the geographic location and size of Canadian biotechnology firms.
Release date: 2001-05-02 - 9. Biotechnology Use and Development - 1999 ArchivedArticles and reports: 88F0006X2001007Description:
This paper provides estimates for firms actively involved in the development of new products and processes using biotechnologies. The survey examines the use of biotechnology and the development of biotechnologies in Canada's industrial sector for the 1999 fiscal year. The Biotechnology Use and Development Survey - 1999 was conducted as part of a project to develop biotechnology statistics and was funded under the Canadian Biotechnology Strategy. Several departments and agencies provided important inputs at various stages of the survey. They are Industry Canada, the Canadian Biotechnology Secretariat, Agriculture Canada, the National Research Council, the Canadian Institutes for Health Research, Natural Resources Canada, Department of Foreign Affairs and International Trade, Health Canada, and Environment Canada.
Release date: 2001-03-30 - 10. Internationally Comparable Indicators on Biotechnology: A Stocktaking, a Proposal for Work and Supporting Material ArchivedArticles and reports: 88F0017M2001009Geography: CanadaDescription:
This paper examines the call for an international effort to co-ordinate the measuring of biotechnology so that the ensuing statistics and indicators maintain some level of international comparability.
Release date: 2001-02-15
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: